Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review the ...

The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the ...